Not an actual patient.
Rely On Redemplo® Patient Support Program
For support, call 1-844-REDEMPLO (1-844-733-3675), Monday to Friday, 8 AM to 8 PM ET
Access Resources
Download the resources below to help you and your office staff assist your patients in starting and staying on track with Redemplo®.
Start Form
Form used to enroll your patients in the Rely On Redemplo Patient Support Program, prescribe Redemplo, and provide patient consent.
Letter of Appeal
A sample letter requesting that a health plan reverse a coverage denial for Redemplo.
Letter of Medical Necessity
A sample letter to help support your clinical rationale for treatment with Redemplo.
Patient Resources
Download the resources below to share with your patients to support them as they begin their treatment journey with Redemplo.
Patient Appeal letter
An example of an appeal letter that a patient or caregiver may reference when requesting that a health plan reverse a coverage denial for Redemplo.
Not an actual patient.
Convenient dosing—one dose every 3 months1
Not an actual patient.
Proven results in patients with FCS1
FCS, Familial Chylomicronemia Syndrome; MCS, Multifactorial Chylomicronemia Syndrome.
REFERENCE Collapse
Collapse
- Redemplo. Prescribing information. Arrowhead Pharmaceuticals, Inc.; 2025.
Indication & Important Safety Information Collapse
Collapse
INDICATION
REDEMPLO® (plozasiran) is indicated as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome (FCS).
IMPORTANT SAFETY INFORMATION
CONTRAINDICATIONS: None.
ADVERSE REACTIONS: Most common adverse reactions in REDEMPLO treated patients (incidence ≥10% of patients treated with REDEMPLO and > 5% more frequently than with placebo) are hyperglycemia, headache, nausea, and injection site reaction.
Please see full Prescribing Information for REDEMPLO.